Literature DB >> 19760858

Review of the current status of tumor enucleation for renal cell carcinoma.

Andrea Minervini1, Agostino Tuccio, Alberto Lapini, Federico Lanzi, Gianni Vittori, Giampaolo Siena, Nicola Tosi, Sergio Serni, Marco Carini.   

Abstract

Tumor enucleation consists of excising the tumor by blunt dissection following the natural cleavage plane between the peritumoral pseudocapsule and the renal parenchyma without removing a visible rim of healthy renal tissue. In the very recent years, the urological current opinion have changed from a wide skepticism against tumor enucleation to a wider level of acceptance based on the lack of correlation between the width of the resection margin and the risk of disease progression/local recurrence and on larger retrospective series on tumor enucleation with longer follow up. The aim of the present review is to report the technique of tumor enucleation, discuss some technical aspects that can vary between centers and to summarize the oncological and surgical results of this technique for the conservative treatment of RCC in the last 10 years; finally, to briefly present the pathological findings on pseudocapsule and surgical margins prospectively evaluated after tumor enucleation.

Entities:  

Mesh:

Year:  2009        PMID: 19760858

Source DB:  PubMed          Journal:  Arch Ital Urol Androl        ISSN: 1124-3562


  3 in total

Review 1.  Simple Enucleation for Renal Tumors: Indications, Techniques, and Results.

Authors:  Adolfo García García; Tania González León
Journal:  Curr Urol Rep       Date:  2016-01       Impact factor: 3.092

2.  Pseudocapsule of renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion: a clue for tumor enucleation?

Authors:  Xiangming Cheng; Jian He; Weidong Gan; Xiangshan Fan; Jun Yang; Bin Zhu; Hongqian Guo
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

3.  Renal Cell Carcinoma Associated with Xp11.2 Translocation/TFE3 Gene Fusions: Clinical Features, Treatments and Prognosis.

Authors:  Ning Liu; Zhen Wang; Weidong Gan; Lei Xiong; Baolei Miao; Xiancheng Chen; Hongqian Guo; Dongmei Li
Journal:  PLoS One       Date:  2016-11-28       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.